Tylenol Isn’t So Safe, But At Least It Works, Right?

Tylenol Isn’t So Safe, But At Least It Works, Right?

https://www.acsh.org/news/2017/09/18/tylenol-isnt-so-safe-least-it-works-right-11827

I’m not a big fan of Tylenol, which becomes rather obvious if you read the first part of this two-part series. For a drug that is so widely used, it is quite easy to consume enough, accidentally or otherwise, to take enough to suffer a toxic overdose due to irreversible liver damage.

But drugs cannot be judged by safety alone. Both the good and the bad – benefits and risks – must be taken into account to get the true measure of the quality of a drug. So if Tylenol isn’t all that safe, you might expect that, at the very least, it should work well. Otherwise, why would so many people be taking it?

That’s the $64,000 question, and here’s the answer. In reality, Tylenol doesn’t work very well at all, and there is plenty of evidence to back this up, especially in systematic Cochrane Reviews – highly regarded, evidence-based reviews that carefully evaluate the quality of data in multiple studies. Here are some representative analyses.

Osteoarthritis of the Knee and Hip

A group of five pain specialists and pharmacologists in Denmark examined seven studies of patients with hip- or knee osteoarthritis. All seven included a comparison between acetaminophen (used continuously for more than two weeks) with placebo. The review, entitled “Acetaminophen for Chronic Pain: A Systematic Review on Efficacy” was published in the journal  Basic & Clinical Pharmacology & Toxicology. The conclusion:

“All included studies showed no or little efficacy with dubious clinical relevance. In conclusion, there is little evidence to support the efficacy of acetaminophen treatment in patients with chronic pain conditions. Assessment of continuous efficacy in the many patients using acetaminophen worldwide is recommended.”

Z. Ennis, et. al., Basic & Clinical Pharmacology & Toxicology, 2016, 118, 184–189

Well, that doesn’t sound so marvelous. Perhaps it’s just a single bad paper. Or not.

Acute and Chronic Lower Back Pain

A 2016 Cochrane Review entitled “Paracetamol for low back pain” (1) examined the utility of Tylenol in treating lower back pain. The review included three trials with a total of 1825 participants, mostly middle-aged, who had acute back pain, and another trial in which the participants had lower back pain for more than six weeks. All of the trials also had a placebo arm. The drug was administered either orally or by IV in doses that ranged from one gram to four grams. How did that work? Ouch.

“We found high-quality evidence that paracetamol (4 g per day) is no better than placebo for relieving acute LBP in either the short or longer term. It also worked no better than placebo on the other aspects studied, such as quality of life and sleep quality.”

B.Saragiotto et. al., Cochrane Review, June 2016

Back Pain, and Hip and Knee Osteoarthritis

The hits keep coming. A 2015 review in the British Medical Journal entitled “Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials” examined reports of 13 randomized trials. The review examined several measures of pain relief: pain intensity, disability, and quality of life in people with low back pain, and hip or knee osteoarthritis. and concluded:

“Paracetamol is ineffective in the treatment of low back pain and provides minimal short term benefit for people with osteoarthritis. These results support the reconsideration of recommendations to use paracetamol for patients with low back pain and osteoarthritis of the hip or knee in clinical practice guidelines.”

M. Ferreira, et. al, BMJ 2015; 350

Headaches

OK, so it doesn’t work for back pain or arthritis, but that’s OK because most people use it for headaches. Well, it works. Sort of. A Cochrane Review entitled “Oral paracetamol for treatment of acute episodic tension-type headache in adults” looks at just that. This may surprise you. 

Things look OK at the beginning of the results sections: “The International Headache Society recommends the outcome of being pain free two hours after taking a medicine. The outcome of being pain free or having only mild pain at two hours was reported by 59 in 100 people taking paracetamol 1000 mg…”

It may not be perfect, but a 59% response isn’t all that terrible. Until you read the rest of the sentence: “…and in 49 out of 100 people taking placebo. This means that only 10 in 100 or 10% of people benefited because of paracetamol 1000 mg.

Now, *that’s* pretty bad. Of the 59 of you who are getting headache relief from the stuff either believed that their headache went away, or it went away within two hours on its own, not from the drug. So, the real efficacy of Tylenol is 10%. That’s enough to give you a headache. 

Colds

Tylenol is often used to treat symptoms of a common cold. For a cold, the data are not as conclusive as in the studies about, but there is little evidence that acetaminophen is effective.

“Acetaminophen may help relieve nasal obstruction and rhinorrhoea [runny nose] but does not appear to improve some other cold symptoms (including sore throat, malaise, sneezing, and cough). However, two of the four included studies in this review were small and allocation concealment was unclear in all four studies. The data in this review do not provide sufficient evidence to inform practice regarding the use of acetaminophen for the common cold in adults.”

S . Li, et. al, “Acetaminophen (also called paracetamol) for the common cold in adults.” Cochrane Review, June 2013

Tooth Pain

For a pain following wisdom tooth extraction, Tylenol is inferior when compared with ibuprofen (Advil), but when two are combined there seems to be a synergistic effect.

“There is high quality evidence that ibuprofen is superior to paracetamol at doses of 200 mg to 512 mg and 600 mg to 1000 mg respectively based on pain relief and use of rescue medication data collected at six hours postoperatively. The majority of this evidence (five out of six trials) compared ibuprofen 400 mg with paracetamol 1000 mg, these are the most frequently prescribed doses in clinical practice. The novel combination drug is showing encouraging results based on the outcomes from two trials when compared to the single drugs.”

E. Bailey et. al, “Ibuprofen versus paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth  Cochrane Review, December 2013

Fever

Tylenol is given to children to lower fever, and it does so successfully. So do NSAIDs, such as aspirin and ibuprofen. There is some indication that giving the two together or alternating the drugs may be more effective, but the evidence is weak. 

“Paracetamol (also known as acetaminophen) and ibuprofen lower the child’s temperature and relieve their discomfort…. There is some evidence that both alternating and combined antipyretic therapy may be more effective at reducing temperatures than monotherapy alone. However, the evidence for improvements in measures of child discomfort remains inconclusive.”

T. Wong, et.al., “Alternating and combined antipyretics for treatment of fever in children.” Cochrane Review, October 2013

This article is not intended to be a comprehensive examination of every review about the efficacy of acetaminophen. There are undoubtedly studies that demonstrate efficacy, however, I chose to include (mainly) information from Cochrane, since it is widely considered to be a high-quality source for evidence-based medicine. 

To wrap this up: acetaminophen largely ineffective. And I have already demonstrated why it is only marginally. This makes it one lousy drug.

Note:

(1) Paracetamol is another name for acetaminophen, the generic name of Tylenol. It is commonly used in Britain.

If you own Johnson and Johnson stock you probably have enough problems on your hands. The company keeps getting hammered by lawsuits alleging that talc in baby powder has given women cancer (1). So you sure don’t need me smacking down Tylenol, which had worldwide sales of almost $2 billion in 2016.

But, don’t blame me. This is not my quote. It’s part of a written interview I did back in July with Aric Hausknecht, M.D, “Pain In The Time Of Opioid Denial: An Interview With Aric Hausknecht, M.D.” 

“Tylenol Is By Far The Most Dangerous Drug Ever Made”

Aric Hausknecht, M.D. July 30, 2017 

Why would Dr. Hausknecht, a New York neurologist and pain management specialist, say this? Taken out of context, such a sweeping statement may seem to be hyperbolic. The most dangerous drug ever made? I asked him to elaborate. He did:

“Each year a substantial number of Americans experience intentional and unintentional Tylenol (acetaminophen) associated overdoses that can result in serious morbidity and mortality. Analysis of national databases show that acetaminophen-associated overdoses account for about 50,000 emergency room visits and 25,000 hospitalizations yearly. Acetaminophen is the nation’s leading cause of acute liver failure, according to data from an ongoing study funded by the National Institutes for Health. Analysis of national mortality files shows about 450 deaths occur each year from acetaminophen-associated overdoses; 100 of these are unintentional.”

Therapeutic Index – A cornerstone of pharmacology

When evaluating drug toxicity, a critical parameter is called the therapeutic index (TI). The TI is the ratio of the toxic dose to the effective dose. Obviously, the higher the TI the better, since the greater the separation of the therapeutic and toxic doses, the less likely an overdose. Here are some examples of low TI drugs:

  • Lithium (bipolar disorder)
  • Warfarin (blood thinner)
  • Theophylline (asthma)
  • Digoxin (various heart conditions)

And some examples of high TI drugs:

  • Benadryl (diphenhydramine, antihistamine, sleep aid)
  • Valium (sedative, hypnotic) (2) 
  • Neurontin (gabapentin, restless leg syndrome, multiple off-label neurological indications)

Tylenol (acetaminophen) an analgesic (pain reliever) gets a free pass in the minds of many people because it doesn’t come with the liabilities of the NSAIDs, such as aspirin and ibuprofen – bleeding, heartburn, kidney toxicity. ulcers, and salicylate allergy. The absence of gastrointestinal toxicity is responsible for the widespread perception that Tylenol is safer. In some ways it is, but in others, it is not. It may leave your stomach alone, but not your liver. 

Dr. Hausknecht’s statistics may seem puzzling. How can there be 50,000 emergency room visits and 25,000 hospitalizations, yet only 450 deaths per year?  This is because, when treated in time, irreversible liver damage from an acute overdose of acetaminophen can be prevented. There is an antidote called N-acetylcysteine. But the danger of the drug is not only from acute doses. Both acute and chronic use of acetaminophen can lead to permanent liver damage, not because acetaminophen itself is toxic, but because the liver converts it into something that is (Figure 1), sealing its own fate in the process. (Apologies for the biochemistry.)

Figure 1: Metabolic activation and detoxification of acetaminophen. Oxidation by liver enzymes forms N-acetylbenzoquinoneimine, a chemically reactive, toxic molecule. The carbon atom (red arrow) irreversibly “attacks” various proteins in the liver. The antidote, N-acetylcysteine sops up (deactivates) the benzoquinone imine, but only if given in time. It does not reverse liver damage. 

So, what is the therapeutic index for Tylenol? You may be rather surprised. Before 2011 the maximum daily dose of acetaminophen recommenced by the FDA was 4,000 mg. It is now 3,000 mg. The estimated lethal dose of the drug is 10 grams in one day, which is not terribly different from the maximum daily dose. The TI is thus about 3, which is pretty bad, especially compared to other drugs which are perceived as far more dangerous:

References:

a) http://www.acutetox.eu/pdf_human_short/1-Acetaminophen%20revised.pdf

b) https://medlineplus.gov/ency/article/002542.htm

c) https://www.fda.gov/ohrms/dockets/dailys/03/Aug03/082903/03p-0398-cp0000…att-6-vol1.pdf

d) https://www.ncbi.nlm.nih.gov/pubmed/357765

** Therapeutic index (TI) is an approximate, but indicative measure of the likelihood of a toxic or lethal overdose. It is not a measure of absolute toxicity, rather, the safety margin between therapeutic and toxic or lethal doses.

Approximate therapeutic indexes for some common drugs. The higher the TI, the lower probability of an overdose. 

 

Rather interesting that the CDC, which has inserted itself firmly up your doctor’s anus for writing scripts for Valium or hydrocodone, is only too happy to recommend that pain patients take a drug that is more likely to cause an overdose than either of them.

“Several nonopioid pharmacologic therapies (including acetaminophen, NSAIDs, and selected antidepressants and anticonvulsants) are effective for chronic pain. In particular, acetaminophen and NSAIDs can be useful for arthritis and low back pain…”

CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

Next: “So, Tylenol isn’t that safe, but at least it works, right?”

NOTES:

(1) It would seem that evidence of harm is totally irrelevant in the courtroom. It is far from clear that talc is harmful. But it is even further from clear that there is *any* proof that Eva Echeverria, a victim of ovarian cancer who used baby powder her whole life, contracted the disease from the powder. Lawyers 1, Science 0.

(2) It is very difficult to die from a Valium overdose in the absence of alcohol, opioids or other central nervous system depressants. (See: “Can Valium Kill You?”). In two case studies, people survived overdoses of 500 and 2,000 mg (50 and 400 five milligram pills, respectively). But, 50 regular strength Tylenol pills (16.25 g) is approximately twice the estimated lethal dose. Yes, a single dose of 500 Valium pills is less dangerous than 50 Tylenol pills. 

Has “professionals oaths” become nothing more than “just words” ?

Hippocratic Oath: Classical Version

I swear by Apollo Physician and Asclepius and Hygieia and Panaceia and all the gods and goddesses, making them my witnesses, that I will fulfill according to my ability and judgment this oath and this covenant:

To hold him who has taught me this art as equal to my parents and to live my life in partnership with him, and if he is in need of money to give him a share of mine, and to regard his offspring as equal to my brothers in male lineage and to teach them this art—if they desire to learn it—without fee and covenant; to give a share of precepts and oral instruction and all the other learning to my sons and to the sons of him who has instructed me and to pupils who have signed the covenant and have taken an oath according to the medical law, but no one else.

I will apply dietetic measures for the benefit of the sick according to my ability and judgment; I will keep them from harm and injustice.

I will neither give a deadly drug to anybody who asked for it, nor will I make a suggestion to this effect. Similarly I will not give to a woman an abortive remedy. In purity and holiness I will guard my life and my art.

I will not use the knife, not even on sufferers from stone, but will withdraw in favor of such men as are engaged in this work.

Whatever houses I may visit, I will come for the benefit of the sick, remaining free of all intentional injustice, of all mischief and in particular of sexual relations with both female and male persons, be they free or slaves.

What I may see or hear in the course of the treatment or even outside of the treatment in regard to the life of men, which on no account one must spread abroad, I will keep to myself, holding such things shameful to be spoken about.

If I fulfill this oath and do not violate it, may it be granted to me to enjoy life and art, being honored with fame among all men for all time to come; if I transgress it and swear falsely, may the opposite of all this be my lot.

“Thank you so much for accepting my friend request. I have no idea what prompted me to contact you but I sit here tonight preparing to check into a psychiatric hospital to detox off the opiates that I was prescribed for almost 15 years and now I can not find a single soul to prescribe them to me. Mine is a textbook case of the hysteria that has overcome our nation. In 2013, after ten years with the same prescribing physician, I was informed that he would no longer be giving any of his patients opiates any longer due to a patient’s death. Obviously, not mine nor did I ever breach the contract, fail a drug screen or ask for early refills. I was on a stable dose for three years, yes it was above the 90mme that is being “suggested” but, it worked for me. I was given a three month supply and sent on my way to pain management where no sooner did the door close behind the PA/NP was I informed that if I didn’t have terminal cancer I would be titrated off all opiates. My thoughts on the matter were irrelevant. I signed myself out of that clinic and then spent the next three years trying to find another pain clinic that would keep me on my prior dose that I was stable and content on. I found no one. My PCP had agreed to “bridge” the gap until I was able to find a provider but that day never came. I was on a medication that didn’t alleviate my pain whatsoever but since he was my primary care doctor he said his hands were tied and that he was out of his comfort zone even prescribing them to me and therefore he wouldn’t adjust the medication the first pain clinic had reduced me to.

I have medical records inches think that document me need for opiates yet each time I would visit a pain doctor I was told that my condition didn’t cause pain or that I was addicted and needed “Suboxone”…blah, blah, blah. My orthopaedic surgeon has written letters that confirm I have a connective tissue disorder and that my bones are the age of a 75-85 year old woman when I am only 46. They don’t want to operate until I am older as the replacement surgery has a high failure risk due to my disorder. I have yet to have one pain doctor even take the time to read my MRI results let alone give me an examination. I can not go to the ER to receive pain relief as they all say they won’t treat chronic pain. The guidelines say this and that. Sorry, see ya’!

So now, my PCP is leaving his clinic and I have no other option but to check into a detox facility. What’s even worse, is that I can not use marijuana as I have a rather strange reaction to it. I’ve tried Kratom as well, nada. Neurontin and gabapentin (spell) both make me feel drunk and stupid. Also, I have been tested and have a confirmed diagnoses of being a poor metaboliser involving the CYP-450 enzyme (I have one allele working at 50%) group with being a rapid metaboliser of methadone enzyme. (C19 I think??) The doctors don’t care. Even with the proof right in front of them. CBD oil is about the only thing I haven’t tried and I have little hope that it will be successful. This is very disappointing and discouraging and if I have to go through withdrawal after 15 years I will too be suicidal which is why I’m checking in. Now, I will definitely be labeled an addict and most likely end up never being prescribed opiates again. I’m supposed to have right foot reconstruction on December 12th and I desperately tried to find a doctor to prescribe to me before because if I have to go through detox I will most likely cancel the surgery so I don’t have to go through this all over again! So, basically I am going to be worse off instead of better after I go through “treatment” for opiate dependence. 

Thank you again, I just wanted to share my story because I honestly do not know what to do at this point, other than wave my white flag and surrender. I love what you’re doing and I sure hope things go back to normal for you soon!! Thanks for reading.

 

Please forgive any errors as I wasn’t able to go back and proofread! Lol. ☺️”

Law Enforcement Oath of Honor

On my honor, I will never betray my badge, my integrity, my character or the public trust.

I will always have the courage to hold myself and others accountable for our actions.

I will always uphold the constitution, my community, and the agency I serve.
Everyone – especially professionals – take a oath to uphold certain standards of their profession. Over the last decade or so… certain professionals seems to regard those oaths as JUST WORDS, and their day to day actions seem to have become more focused on SELF-SERVING.

 

DEA Agent: no one should be taking opiates unless they have cancer

As pharmacists we are in a tough spot. I had a DEA agent stand in my pharmacy and watch as a lady handed over a stack of narcotics rxs to the technician. He said no one should be taking those unless they have cancer. ( his words, not mine). This same DEA agent told me I shouldn’t be dispensing diet pills to someone if I judge them to be thin. ( now, my definition of thin bight be different than his). My point is I don’t think it’s my place to be the judge. Also, I don’t see the patient in an office to get all the facts. I don’t always know why someone is taking those pills. According to him, it IS my job to be the judge. I trust the doctor to make that decision, but we aren’t supposed to do that either!

sadly when they are standing there with a gun, you just end up doing what they say when they threaten you…..
No doubt this guy is a total jerk. I did ask him if he was a pharmacist or doctor, as an indication that I thought he had no expertise. He’s not either and didn’t care.

Montana: the “land of denial of pain” ?

It is because we are only being shown one side of this story

Op-ed: Chronic pain sufferers need access to opioids

https://www.deseretnews.com/article/865688783/Op-ed-Chronic-pain-sufferers-need-access-to-opioids.html

My 26-year-old daughter, Madison, is an extremely intelligent, articulate, creative and beautiful young woman. Anyone blessed with these attributes should be well on their way to a wonderful and fulfilling life. But Madison is suffering in ways that most people could never imagine. Diagnosed at 13 years old with Complex Regional Pain Syndrome, formerly known as Reflex Sympathetic Dystrophy (CRPS/RSD), an incurable and progressive chronic pain disease of the sympathetic nervous system, she lives every day in severe pain.

CRPS/RSD is ranked as the most painful form of chronic pain that exists today by the McGill Pain Index. With the advice of numerous physicians over the last 13 years, we have tried every possible remedy and every possible treatment. None of them worked. So many days, I can only hold her in my arms as she cries in agony. The only thing that eases her suffering slightly is her prescription of opioid medication. Yet the government, in a short-sighted effort to combat widespread opioid abuse, wants to take Madison’s lifeline away. She, along with many others in her situation, are apparently considered collateral damage.

Collateral damage is not acceptable. Our military does the best it can to minimize collateral damage on the innocent and unintended targets even if it means sparing the intended targets. This is supported by not only by our government, but by the international community as well. And it should be that way. It’s compassionate.

Why, then, is our government inflicting cruel and unusual punishment for innocent victims here at home? They are putting extreme pressure upon physicians, under the threat of being removed from their practice, to reduce and/or eliminate the levels of prescribed opioids to all patients. But there will be collateral damage to this. Tens of thousands of people who have chronic pain will suffer. For them, there is no relief without opioid medication, and for whom the reduction or the elimination of their medication will cause unspeakable pain and even death.

The United Nations Universal Declaration of Human Rights states in Article 5, “No one shall be subjected to torture or to cruel, inhuman or degrading treatment or punishment.” Medical doctors in the United States take the Hippocratic Oath that states, “I will follow that system of regimen which, according to my ability and judgment, I consider for the benefit of my patients, and abstain from whatever is deleterious and mischievous.”

How can we be in direct conflict to both the Declaration of Human Rights and the Hippocratic Oath, and cause immense suffering to those of us who are in chronic, incurable pain? How can we reconcile the fact that, as a country, we can show compassion and lend assistance to refugees, and send food and medical aid to Third World countries, yet allow our family and friends to be denied the medication they need to survive?

It is because we are only being shown one side of this story. What we are not shown are the millions of patients in the USA alone who, but for their opioid medication, would be left in constant and excruciating pain. Taking away their right to be treated for their pain is the real opioid crisis.

Sadly, there are thousands of people who die from the over-the-counter drug ibuprofen every year. There are tens of thousands of people dying from their antidepressants and benzodiazepines. There are hundreds of thousands of people who die from complications associated with anticoagulants. Although these numbers are tragic, we would not want to see the physicians associated with these prescriptions threatened. This, however, is exactly what is happening in the case of the opioid crisis.

This is not acceptable.

Physicians Get Too Much Blame for Opioid Crisis, Some Say

Physicians Get Too Much Blame for Opioid Crisis, Some Say

http://www.medscape.com/viewarticle/885760

SAN ANTONIO, Texas — People looking to place blame for the nation’s opioid crisis too often point the finger at physicians, some speakers said at a reference committee for the American Academy of Family Physicians (AAFP) 2017 Congress of Delegates.

As communities across the country deal with the escalating opioid crisis, clinicians, public health officials, and the public are increasingly looking for answers, solutions, and — sometimes — where to place blame.

Several resolution clauses presented in a committee hearing Monday addressed shared responsibility and the need for education of physicians, officials, and the public on evidence-based prescribing. But the clause that caught the most attention directed the AAFP to mount a nationwide public relations effort to “dispel the myth that places blame on physicians.”

Some delegates who spoke against the resolution pointed to the large cost estimated for the proposal (more than $550,000 for a 12-month campaign). Others noted that changing minds would take time. And some simply said it was not a road AAFP should take.

 

However, the resolution passed the committee and was referred to the AAFP board on Wednesday.

Timothy Alford, MD, a delegate from Mississippi, which sponsored the resolution, said, “I can tell you we’ve got good physicians in rural America, right in the wheelhouse of what we do, where this problem is very pervasive, and they’re getting thrown under the bus by the press, and everybody else.”

David Hoelting, MD, a delegate from Nebraska, told Medscape Medical News, “Physicians, especially family physicians and orthopedists, are receiving the most pressure for prescriptions of opiates. A lot of this started as a result of the “fifth vital sign” program started around year 2000. First there was pressure to relieve all pain, then when addiction levels soared, we got the blame. The most serious problem now is that physicians are stopping narcotics to many of the patients abruptly, forcing them to resort to illegal street drugs, and risking overdoses.”

Jim Taylor, MD, an alternate delegate from Louisiana, said the issue has become a political football.

The perception battle is one we’re losing. I think a half-million dollars is a very reasonable amount to spend on a national campaign to push back against those who actually push us into this.”

Other clauses in the resolution included asking that the AAFP to support appropriate and individualized pain treatment by physicians, educate family physicians in evidence-based pain management and prescribing, and educate government and law officials that a balanced approach is needed.

Clauses also promoted prescription monitoring and cognitive-behavioral therapy.

Domenic Casablanca, MD, a delegate from Connecticut, said those parts of the resolution are already being covered by current AAFP policy and launching the public relations campaign would take the academy in the wrong direction.

 

“Our delegation felt strongly there’s nothing to be gained in terms of making us look better by the PR campaign. It’s a multifactorial problem and we don’t want to lower ourselves to that level,” he said.

 

Dennis Dmitri, MD, a delegate from Massachusetts, said 2 years ago political will had turned against physicians, and physicians in the state were getting blamed for the opiate crisis.

 

It wasn’t until physicians sat down with government officials and legislators to work cooperatively with them, rather than defensively, on the issue that the tide turned, he said. That had a positive effect on the kind of legislation that was subsequently passed.

 

Dr Dimitri said the Massachusetts Medical Society launched a public relations campaign, but “not one aimed at buffing the reputation of physicians.” Instead it was aimed at educating the public about why there is an opioid crisis, how it could be addressed, how members of the public could be more careful about their own use of opiates, and how they could better interact with their physicians.

 

“That really changed the perception of physicians and the role they might play,” he said, “other than simply trying to say it’s not our fault.”

Five myths about heroin

Five myths about heroin

https://www.washingtonpost.com/opinions/five-myths-about-heroin/2016/03/04/c5609b0e-d500-11e5-b195-2e29a4e13425_story.html?utm_term=.616c93a6ee4d

America’s epidemic of heroin and prescription-pain-reliever addiction has become a major issue in the 2016 elections. It’s worse than ever: Deaths from overdoses of opioids (the drug category that includes heroin and prescription analgesics such as Vicodin) reached an all-time high in 2014, rising 14 percent in a single year. But because drug policy has long been a political and cultural football, myths about opioid addiction abound. Here are some of the most dangerous — and how they do harm.

1. Most heroin addiction starts with a legitimate pain prescription.

People who misuse prescription pain relievers are 40 times more likely to become addicted to heroin than those who don’t, according to the Centers for Disease Control and Prevention. Research also shows that 75 percent of patients in heroin treatment started their opioid use with prescription medications, not heroin. That sounds like pain treatment is at the root of the problem, and the CDC is targeting doctors with new guidelines aimed at reining in prescriptions.

But overwhelmingly, prescription-drug misusers are not pain patients. According to the National Survey on Drug Use and Health, more than 75 percent of recreational opioid users in 2013-14 got pills from sources other than doctors, mainly friends and relatives. Even among this group, moving on to heroin is quite rare: Only 4 percent do so within five years; just 0.2 percent of U.S. adults are current heroin users.

The proportion of patients who become newly addicted to opioid medications during pain treatment is also low. A 2010 Cochrane review — considered the gold standard for basing medical practice on evidence — found an addiction rate of less than 1 percent. A study of more than 135,000 emergency-room visits for opioid overdose found that just 13 percent of patients had a chronic pain diagnosis.

Further, a 2015 study showed that only 6 percent of those who received an initial prescription for opioids took the drugs for more than four months; the authors didn’t determine how many of those ongoing prescriptions were medically appropriate and what proportion were linked to addiction.

The real risk factor for opioid addiction is youth. Like 90 percent of all addictions, the vast majority of prescription-drug problems start with experimentation in adolescence or early adulthood, typically after or alongside binge drinking, marijuana smoking and cocaine use. Having a prior or current addiction to another drug is the best predictor of developing problems with prescription drugs — not pain care.

2. The best treatment for heroin addiction is inpatient rehab.

When the media covers addiction among the rich and famous, they almost always include an inpatient stay at a plush rehab center. Dr. Drew Pinsky’s “Celebrity Rehab” is typical of such programs. Like many who run inpatient programs, Pinsky rejects the ongoing use of anti-addiction medication (though Hazelden, the original model for the 28-day rehab center, began offering it to some patients in 2012 after experiencing record high death rates). Similarly, most drug courts and many state Medicaid programs also deny continuing access to the two best-studied maintenance medications, methadone and buprenorphine (Suboxone).

The position that residential treatment centers and their abstinence-only philosophies are superior to medication ignores overwhelming data and keeps families from seeking the best care. Let’s start with Dr. Drew’s patients: Nearly 13 percent who appeared on “Celebrity Rehab” died not long afterward; most had been addicted to opioids. While that may be an especially poor showing, research on more than 150,000 patients receiving treatment for opioid addiction in Britain found that people in abstinence-only care had double the death rate of those who received ongoing maintenance treatment. And other studies find that maintenance medication cuts death rates by 70 percent or more. Since untreated heroin addiction carries a mortality rate of 2 to 3 percent per year, the benefit is substantial.

This is why the World Health Organization, the National Institute on Drug Abuse, the Institute of Medicine and the White House drug czar’s office all agree that maintenance treatment — indefinite, possibly lifelong medication use — is superior to abstinence rehab for opioid addiction. While some argue that total abstinence is a moral imperative, dead people can’t recover. Sadly, only a small proportion of people with opioid addiction are currently in medication-assisted treatment — largely because of limits placed on it by misguided ideology, government policies and insurers.

 3. Recovery from heroin addiction is rare.

The prognosis for heroin addiction seems grim because of the high mortality rate and because rehabs typically report relapse rates of 60 percent or greater. However, the odds of recovery are better than they appear.

Early evidence for this idea came from studies of Vietnam veterans, who, as young men, should have had particularly high addiction and relapse risk. Heroin and opium were cheap and easily available to American servicemen overseas; nearly half tried these drugs, and half of these soldiers became addicted. But upon returning home, just 12 percent of those who had been addicted relapsed within three years, and only 2 percent were still addicted at the end of the study — nowhere near 60 percent. Fewer than half got any treatment, and it didn’t make a difference in terms of who recovered.

This phenomenon, known as “natural recovery” or “maturing out” of addiction, is common with other drugs, too. Large population surveys show that most people who are addicted to alcohol or cocaine quit without treatment. The same type of study shows that around 60 percent of people who met the criteria for prescription opioid addiction at one time no longer do so — and one third of them never received any treatment. This research also finds that the average prescription opioid addiction lasts eight years; for heroin, the average is a decade. For alcohol, the average addiction lasts 15 years.

So why do heroin addicts appear so hopeless in the public imagination? Because people who quit on their own don’t show up for treatment — and so, while they are included in large epidemiological studies, they aren’t included in treatment research. This means that rehabs see only the worst cases, leading to an unduly pessimistic picture of recovery. Although opioid addiction certainly can be deadly, it doesn’t have to be — and those who struggle with it should absolutely seek help. Still, more research is needed to understand what people who recover without help can teach those who need it.

4. Tough love is the only thing that works.

The idea that people with addiction must “hit bottom” — or experience the worst possible consequences — before they can get better is prevalent among parents and policymakers. One drug court official told a researcher that “force is the best medicine” for treating addiction, and the 12-step program Al-Anon warns against “enabling” addiction by doing things like helping people avoid jail.

But research shows that the opposite is true. Like any other human beings, people with addiction respond best to being treated with dignity and respect. Programs that nonjudgmentally distribute clean needles, provide overdose-reversal drugs or offer safe spaces for injection do not prolong addiction; a Canadian study found that 57 percent of people who came to a safe injection facility to shoot up ultimately entered treatment . An approach for helping addicted family members that uses kindness, rather than confrontation or detachment, was found in another study to be twice as effective as a traditional confrontational “intervention” — and no studies show that harsh treatment or incarceration is superior to empathetic care.

Similarly, there’s no evidence that naloxone programs, which provide users and their families with the overdose-reversal drug, prolong addiction. But they do prolong life: The overdose death rate was cut by nearly 50 percent in communities that fully implemented these programs.

5. Whites have recently become the majority of people with heroin addiction.

In an article headlined “In Heroin Crisis, White Families Seek Gentler War on Drugs,” the New York Times recently claimed that “today’s heroin crisis is different,” because it is not “based in poor, predominantly black urban areas” and because use “has skyrocketed among whites.” NPR, the Atlantic and other major media outlets have run similar stories, often citing a study, published in JAMA Psychiatry, which found that 90 percent of new heroin users in the past decade were white.

What most of them omit is that the same study showed that whites have made up more than half of all heroin addicts since the early 1970s and hit 80 percent before 2000. In 1981, Newsweek panicked about a new wave of “middle-class junkies,” and in 2003, a Times headline read “Heroin’s New Generation: Young, White and Middle Class.” White heroin users are nothing new.

The reason for the misperception is political: Politicians from the first “drug czar,” Harry Anslinger, in the 1930s to Ronald Reagan in the 1980s have portrayed heroin and other illegal drugs as a black or “foreign” problem in order to justify tough policies. In the early 1900s, when heroin was sold over the counter without warning labels, the typical user was a white middle-class woman, and she was seen as a victim of unscrupulous manufacturers, not a criminal. After heroin became illegal and was framed as a problem of the poor and minorities, law enforcement began to predominate. Only now are policymakers beginning to recognize the failure of criminalization.

 

CDC: Updated Influenza Immunization Recommendations for 2017-2018

CDC: Updated Influenza Immunization Recommendations for 2017-2018

It is recommended that flu shots should be given by the end of Oct because it takes a couple of weeks for full immunity to build up.  Conversely, there is new evidence that getting a flu shot “early” (Aug-Sept) that the effectiveness of the flu vaccine may have “faded enough” by the time of the peak flu season that the pt may be at risk of catching the flu.  Especially those pts with compromised immune systems (FM, RA, MS, etc) might be advised to get their flu shots in the last two weeks of Oct each year.

http://www.empr.com/news/flu-season-vaccine-quadrivalent-trivalent-acip/article/684558/

The Advisory Committee on Immunization Practices (ACIP) has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2017–2018 season. 

For the 2017–2018 season, the following influenza vaccines will be available:

  • Trivalent influenza vaccine (A/Michigan/45/2015 (H1N1)pdm09–like virus, an A/Hong Kong/4801/2014 [H3N2]-like virus, and a B/Brisbane/60/2008–like virus [Victoria lineage])
  • Quadrivalent influenza virus (includes three viruses listed for Trivalent vaccine + additional B vaccine virus [B vaccine virus, a B/Phuket/3073/2013–like virus])
  • Recombinant influenza vaccine (both trivalent and quadrivalent)

Due to concerns about its effectiveness, live attenuated influenza vaccine (FluMist Quadrivalent; MedImmune) is NOT recommended for use during the 2017–2018 season. According to Penn State College of Medicine researchers, influenza vaccination rates for the 2016–2017 flu season among children decreased by 1.6% (compared to 2015–2016 rates) after this recommendation was made. “We worried that there was going to be a huge drop off in vaccination rates without the nasal spray available,” said study co-author Ben Fogel, assistant professor of pediatrics at Penn State College of Medicine and medical director of Penn State Pediatric Primary Care. “We saw a drop off but I would not call it huge, which is reassuring.”

In general, routine annual vaccination is recommended for all patients ≥6 months of age who have no contraindications. Flu vaccine should be offered to patients by the end of October, if possible.

Related Articles

The major updates for this upcoming flu season include the following:

  • A change in the influenza A(H1N1)pdm09 virus component from the previous season
  • The availability of Afluria Quadrivalent (Seqirus), an inactivated influenza vaccine indicated for active immunization against influenza A subtype viruses and type B viruses for patients 18 years of age and older
  • The availability of Flublok Quadrivalent (Protein Sciences), a recombinant protein-based vaccine for active immunization against disease caused by influenza A virus subtypes and influenza B virus in patients 18 years of age and older
  • An expanded age range for FluLaval Quadrivalent (GlaxoSmithKline) to include use in children aged ≥6 months (previously approved in patients aged ≥3 years)
  • Pregnant women may receive any FDA-approved, recommended, age-appropriate influenza vaccine
  • Patients 5 years of age and older may now receive Afluria (Seqirus), a trivalent, inactivated “split virion” influenza vaccine
  • While still a licensed product, the ACIP does not recommend use of live attenuated influenza vaccine

The full report, which includes guidance for influenza vaccination of specific populations (ie, children, pregnant women, older patients, immunocompromised individuals), and situations (history of Guillain-Barré Syndrome, egg allergy) can be found here.

Congress Makes Progress in Destroying the Americans With Disabilities Act

Congress Makes Progress in Destroying the Americans With Disabilities Act

www.rewire.news/article/2017/09/11/congress-makes-progress-destroying-americans-disabilities-act/

From literally putting their bodies on the line to save the Affordable Care Act to contending with a presidential administration that has demonstrated complete disdain for them, people with disabilities are facing unprecedented times. Last week, things went from bad to worse for us: Congress took significant steps in its efforts to destroy the landmark Americans With Disabilities Act (ADA).

As I have written previously for Rewire, Congress is considering the ADA Education and Reform Act of 2017 (HR 620), sponsored by Rep. Ted Poe (R-TX). If passed, this dangerous legislation would completely undermine the intent of the ADA and significantly harm the rights of people with disabilities.

Because of the ADA, businesses—such as restaurants, movie theaters, hospitals, hotels, and museums—must be fully accessible to people with disabilities. In addition, the ADA compels employers, as well as public and private entities including state and local governments, to provide reasonable accommodations to people with disabilities and prohibits discrimination based on disability.

Right now, if a disabled person faces an ADA violation, such as inaccessibility, at a business, they can file a complaint with the U.S. Department of Justice (DOJ) or file a lawsuit in court. Because there is no entity responsible for ensuring that businesses comply with the ADA, enforcement depends on people with disabilities to challenge violations.

Put briefly, if the ADA Education and Reform Act is passed, this will be a much more difficult process. Specifically, if HR 620 is passed, a person with a disability would be obligated to provide written notice to a business owner who has violated the ADA. The business owner would then have 60 days to even acknowledge that there is a problem and another 120 days to make progress toward correcting the violation. In other words, people with disabilities will have to wait 180 days to enforce their civil rights.

According to a letter to the House Judiciary Committee last week by 236 disability and civil rights organizations, “H.R. 620 was not written in consultation with representatives of the disability rights community and it would create barriers to the civil rights for persons with disabilities that do not exist in other civil rights laws.”

Despite this strong condemnation, however, the House Judiciary Committee held a markup hearing on Thursday where it voted HR 620 out of committee. The final vote was 15 to 9 along party lines; all of the amendments proposed by Democrats, including additional damages if a business fails to make progress after 120 days, were rejected. The ADA Education and Reform Act of 2017 will now move to a full House floor vote.

In response to this appalling vote, the National Disability Rights Network issued a statement on Friday: “More than 27 years after the passage of the ADA, the committee’s vote was not an attempt to reform or educate on the ADA, but a blatant attempt by Congress to say that it is ok to discriminate against people with disabilities by not making public accommodations accessible.”

Disability rights advocates were not the only ones to release scathing remarks in response to the vote. Ranking member Rep. Bobby Scott (D-VA) issued a press release expressing his disappointment that read, “H.R. 620 undermines the goals of the ADA to create a more inclusive society and provide equal participation for all members of the community by removing incentives to comply with ADA requirements, placing the compliance burden on individuals with disabilities.”

Likewise, Sen. Tammy Duckworth (D-IL), a disabled veteran and wheelchair user, wrote on Facebook, “It’s hard to believe this legislation advanced in the House this week. 27 years after the Americans With Disabilities Act became the law of the land, the notion that businesses in this country need more time to provide people with disabilities access to their services is ridiculous and offensive.” Referencing the pro-ADA protest in 1990, she continued, “This vote is a disgrace to those who literally crawled up the steps of the United States Capitol so many years ago to secure the protections enshrined in the ADA as well as to all those who value liberty and justice for all.”

Other members of Congress, including Sen. Maggie Hassan (D-NH), Sen. Patty Murray (D-WA), and Sen. Bob Casey (D-PA), issued similar statements condemning the House Judiciary Committee’s vote and committing to oppose passage of the bill in the Senate.

Of course, many business representatives, including the International Council of Shopping Centers, are celebrating the House Judiciary Committee’s vote.

Throughout the years, based on a false belief that the ADA is being abused via frivolous lawsuits, Congress has introduced a number of “notification bills”—which shift the burden of enforcement further onto people with disabilities—such as HR 620. But their passage has never seemed so likely as now. Individuals must join the efforts to stop this assault on the ADA by contacting their members of Congress, signing online petitions, and most importantly, joining the disability community as we continue to fight this dangerous legislation.

Considering that the U.S. president’s real-estate properties have violated the ADA on numerous occasions, the bill is certain to be signed into law if it crosses his desk. Today it is the ADA on the chopping block; tomorrow it may be another civil rights law.

 

Lady Gaga hospitalized for ‘severe pain’

Lady Gaga hospitalized for ‘severe pain’

http://www.foxnews.com/entertainment/2017/09/14/lady-gaga-hospitalized-for-severe-pain.html

Lady Gaga cancelled her Rock In Rio concert in Brazil Thursday after announcing she was suffering from “severe physical pain.”

The 31-year-old made the announcement on Twitter.

It was later confirmed on her social media that the pop star was hospitalized and is being watched over by “the very best doctors.”

The singer revealed earlier this week she suffers from fibromyalgia, a chronic disorder that causes widespread muscle pain.

Back in 2013, Gaga was forced to cancel several tour dates to have surgery on her broken hip.

She opened up about that painful procedure in her new Netflix documentary “Gaga: Five Foot Two,” which premieres Sept. 22.